These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. Bao F; Yu L; Babu S; Wang T; Hoffenberg EJ; Rewers M; Eisenbarth GS J Autoimmun; 1999 Aug; 13(1):143-8. PubMed ID: 10441179 [TBL] [Abstract][Full Text] [Related]
27. Physiopathology and Management of Gluten-Induced Celiac Disease. Kumar J; Kumar M; Pandey R; Chauhan NS J Food Sci; 2017 Feb; 82(2):270-277. PubMed ID: 28140462 [TBL] [Abstract][Full Text] [Related]
28. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects. Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408 [TBL] [Abstract][Full Text] [Related]
29. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852 [TBL] [Abstract][Full Text] [Related]
30. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization. Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572 [TBL] [Abstract][Full Text] [Related]
31. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Vader W; Stepniak D; Kooy Y; Mearin L; Thompson A; van Rood JJ; Spaenij L; Koning F Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12390-5. PubMed ID: 14530392 [TBL] [Abstract][Full Text] [Related]
32. Diagnosis and classification of celiac disease and gluten sensitivity. Tonutti E; Bizzaro N Autoimmun Rev; 2014; 13(4-5):472-6. PubMed ID: 24440147 [TBL] [Abstract][Full Text] [Related]
33. Management of celiac disease in daily clinical practice. Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262 [TBL] [Abstract][Full Text] [Related]
34. Local communication among mucosal immune cells in patients with celiac disease. van Bergen J; Mulder CJ; Mearin ML; Koning F Gastroenterology; 2015 May; 148(6):1187-94. PubMed ID: 25623043 [TBL] [Abstract][Full Text] [Related]
35. Interplay Between Gluten, HLA, Innate and Adaptive Immunity Orchestrates the Development of Coeliac Disease. Voisine J; Abadie V Front Immunol; 2021; 12():674313. PubMed ID: 34149709 [TBL] [Abstract][Full Text] [Related]
36. Gluten: a two-edged sword. Immunopathogenesis of celiac disease. Koning F; Gilissen L; Wijmenga C Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925 [TBL] [Abstract][Full Text] [Related]